Ziqin Deng

Chinese Academy Of Medical Sciences And Peking Union Medical College
Beijing, 100021, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Plasma proteomic and metabolomic profiling reveals molecular features relevant to neoadjuvant therapy response in locally advanced esophageal squamous cell carcinoma.

Plasma proteomic and metabolomic profiling reveals molecular features relevant to neoadjuvant therapy response in locally advanced esophageal squamous cell carcinoma.

Journal: Molecular cancer

Published: January 14, 2026

GAB3 suppresses lung adenocarcinoma progression by inhibiting the MAPK signaling and potentiating CD8+ T cell immunity.

GAB3 suppresses lung adenocarcinoma progression by inhibiting the MAPK signaling and potentiating CD8+ T cell immunity.

Journal: Cancer letters

Published: December 12, 2025

RAD21 drives tumor progression and confers anti-PD-1 resistance by reprogramming tumor-associated macrophages via upregulation of CSF1 signaling.

RAD21 drives tumor progression and confers anti-PD-1 resistance by reprogramming tumor-associated macrophages via upregulation of CSF1 signaling.

Journal: Cancer letters

Published: December 12, 2025

RAD21-mediated epigenetic regulation promotes lung adenocarcinoma progression and sensitizes cancer cells to ERK-targeted therapy.

RAD21-mediated epigenetic regulation promotes lung adenocarcinoma progression and sensitizes cancer cells to ERK-targeted therapy.

Journal: Cancer letters

Published: July 29, 2025

SLAMF receptors: key regulators of tumor progression and emerging targets for cancer immunotherapy.

SLAMF receptors: key regulators of tumor progression and emerging targets for cancer immunotherapy.

Journal: Molecular cancer

Published: December 10, 2024

The epigenetic hallmarks of immune cells in cancer.

The epigenetic hallmarks of immune cells in cancer.

Journal: Molecular cancer

Published: November 17, 2024

Neutrophils in cancer: At the crucial crossroads of anti-tumor and pro-tumor.

Neutrophils in cancer: At the crucial crossroads of anti-tumor and pro-tumor.

Journal: Cancer communications (London, England)

Published: September 19, 2024

Signatures of H3K4me3 modification predict cancer immunotherapy response and identify a new immune checkpoint-SLAMF9.

Signatures of H3K4me3 modification predict cancer immunotherapy response and identify a new immune checkpoint-SLAMF9.

Journal: Respiratory research

Published: August 22, 2024

Targeting LSD1 in cancer: Molecular elucidation and recent advances.

Targeting LSD1 in cancer: Molecular elucidation and recent advances.

Journal: Cancer letters

Published: May 09, 2024

The pathogenic germline ETV4 P433L mutation identified in multiple primary lung cancer affect tumor stem-like property by Wnt/β-catenin pathway.

The pathogenic germline ETV4 P433L mutation identified in multiple primary lung cancer affect tumor stem-like property by Wnt/β-catenin pathway.

Journal: Cell death & disease

Published: December 04, 2023

KLF12 overcomes anti-PD-1 resistance by reducing galectin-1 in cancer cells.

KLF12 overcomes anti-PD-1 resistance by reducing galectin-1 in cancer cells.

Journal: Journal for immunotherapy of cancer

Published: July 26, 2023

H3K4 trimethylation regulates cancer immunity: a promising therapeutic target in combination with immunotherapy.

H3K4 trimethylation regulates cancer immunity: a promising therapeutic target in combination with immunotherapy.

Journal: Journal for immunotherapy of cancer

Published: May 03, 2023

Showing 1-12 of 14

Last Updated: 09/26/2026